Making a difference in breast cancer
Breast cancer is the world's most prevalent female cancer, with 2.3 million women diagnosed in 2022 (1).
It is a complex group of tumors with diverse histology and molecular signatures. Some genomic alterations in breast cancer are clinically actionable with targeted therapies. Understanding these biomarkers, and then developing therapies that target them, is the key to improving diagnosis and treatment.
Discover how we can help take your breast cancer care and clinical research to the next level.